Delivery Order SPE2DX15D3012-SPE2DX24F8DS6
Award Date
11/8/23
Potential Completion Date
11/9/23
Potential Value
$23K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,146.85, is for the delivery of 4,562,252,590 units of the pharmaceutical product Ondansetron ODT 8 mg Tablet 30s. This is a Firm Fixed Price Delivery Order contract with a completion date of September 21, 2023. The contract has no set-aside designation, indicating full and open competition. Amerisourcebergen...
This federal contract award, with ID SPE2DX15D2101|SPE2DX24F49XS, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,563,617,321 units of the pharmaceutical product Ondansetron ODT 4 mg tablet. The contract has a ceiling value of $1,906.02 and a completion date of February 12, 2024. This is a firm fixed-price delivery order contract with no set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ondansetron ODT 8 mg tablets. The contract, valued at $3,574.89, has a completion date of January 26, 2024 and is a firm-fixed-price delivery order. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,245.96 firm fixed-price delivery order is for 4,564,413,840 units of the medication Ondansetron ODT 4 mg tablet. The contract has an ultimate completion date of April 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA and Cencora, Inc. valued at up to $999,999,999.00, which serves as...
This federal contract award, valued at $17,249.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order for the supply of 4563818472 Ondansetron ODT 4 mg tablets, with a completion date of March 1, 2024. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $7,840.40, is for the delivery of 4,563,018,998 units of the medication Ondansetron ODT 4 MG Tablet 30S. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of December 7, 2023. The contract was awarded on December 6, 2023 and does not have a set-aside...
This federal contract award, with ID SPE2DX15D2213|SPE2DX24F7Z8B, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Ondansetron HCL 4 mg tablets in 30-count packages, with a ceiling value of $13,853.07 and a completion date of March 7, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,562,056 units of ondansetron ODT 4 mg tablets. The contract, valued at $7,151.94, is a firm fixed-price delivery order with a completion date of September 6, 2023. The award is not associated with any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This federal contract award is from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Ondansetron ODT 4 mg tablets to support military and government healthcare programs. The total ceiling value of the contract is $3,607.41, with a period of performance through November 20, 2023. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating...
This federal contract award, with ID SPE2DX15D6040|SPE2DX24F3GNY, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $5,362.36 firm fixed-price delivery order is for 4,564,834,366 units of the pharmaceutical product Ondansetron ODT 4 mg Tablet 30s. The contract has an ultimate completion date of June 10, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...